Led and closed asset acquisition by Kwivik Therapeutics, Inc., a wholly owned subsidiary of the group. Invested USD $7 million of over USD $35 million total in company.
30+ years experience in biotech/medtech, high tech, R&D, manufacturing, sales and corporate finance.
Public and private company experience includes IPOs and M&A; development of production capabilities, development of sales, distribution and licensing partnerships; and financings with debt and equity (career total in excess of USD $1 Billion).
Other experience: (i) A roll-up of network integration, infrastructure engineering and data centre (managed) services companies in the late 90’s; (ii) A USD $315 million high yield debt offering in 1996 for Isle of Capri Casinos, Inc. (with Merrill Lynch/Salomon Brothers in lead, plus Deutsche Morgan Grenfell, Nomura Securities); With that financing, Isle of Capri grew from $134 million in revenues to over $1 billion in revenues in less than five years, and was subsequently acquired by Eldorado Resorts (it was recently announced that Eldorado Resorts is acquiring MGM Grand for over USD $8 Billion); (iii) Founder investor and director in highly successful, USD $400 million capex gaming & hospitality operation in South Africa.
Named to the “40 Under 40” by the Dallas Business Journal and his company was selected by the USPTO and the Smithsonian Museum (from thousands of patentholders worldwide) to exhibit at the USPTO’s inaugural Innovation Expo (along with Ford, Caterpillar, Qualcomm and six other innovative companies).
Holds 7 issued patents (with several more pending) and an M.B.A. in Finance from Southern Methodist University, with full ride scholarships from oil & gas giant Shell Petroleum (undergraduate) and the Edwin L. Cox School of Business (post graduate).
Robert Fox, CPA
Chairman, Audit Committee
38+ Years experience in accelerating growth, creative problem solving, operations management, accounting, audit and finance.
Spent 32 years at a Nasdaq listed Fortune 200 company with in excess of 60,000 employees and over $25 billion in revenues, mastering roles including Chief Accounting Officer, Division CFO Manufacturing, and Senior Manager Global Development.
Functional responsibilities included GAAP and SEC compliance, GAAP public, IFRS and SEC reporting, internal controls and auditing, financial planning and analysis, budgets and financial plans, mergers and acquisitions, operations, manufacturing (including Lean Six Sigma), logistics and procurement.
Led finance teams at two additional Fortune 500 companies listed on multiple exchanges including the SIX Swiss Exchange in Zürich, Nasdaq Stockholm and the New York Stock Exchange.
Served as strategic advisor to various private equity and public companies focused on strategic growth, turnarounds, mergers, acquisitions, divestitures and carveouts, automation and special projects.
Holds a CPA in the State of Texas.
Rohan Hoare, PhD
Chairman, Nominating Committee
Proven leader with demonstrated success in the medical device industry. Skilled in Market Development, Commercialization, Strategy, Product Development, Clinical Research, Quality and Manufacturing
Career highlights spanning over 35 years include: 9 years at Neuromodulation Division at St. Jude Medical, culminating in President role; COO at Cyberonics/President Neuromodulation LivaNova, 10 years at McKinsey & Company; 3 years as President & CEO of EndoStim; and 3 years as Emergency Service Officer for the National Safety Council of Australia
Serves on the Board of Nexstim, Helsinki, Finland
PhD in Physics from Harvard University and a BS (Hons), Physics from Monash University
Luis M. Salmun, MD
Chief Medical Officer
Over three decades experience in medicine and medical affairs, research, clinical, healthcare insurance, and regulatory registration and approvals; with specialties that include Immunology and Allergy, Asthma, COPD, Cardiovascular Disease, Diabetes and Pediatrics
Former Instructor, Harvard Medical School; Medical Advisor, Asthma & Allergy Foundation of America
Career highlights include: Sr. Vice President, Global Medical Affairs, DBV Technologies; Executive Director, Health Science Executives / Head, Health Science Executives, Boehringer-Ingelheim; Vice President & National Practice Leader, Pulmonary and Immunology – Therapeutic Resource Centers, Medco Health Solutions; Executive Director, Medical Affairs, Mylan (Medical Affairs global responsibilities for the EpiPen auto-injector franchise); Executive Director, WorldWide Consumer Medicines, Bristol-Myers Squibb Company; Sr. Director, Consumer Health Care, Schering-Plough Corporation
Widely published, including New England Journal of Medicine, Journal of Allergy and Clinical Immunology, Clinical Therapeutics, Immunology News, Medico Interamericano, and Annals of Allergy and Clinical Immunology.
Jeff Robertson, CPA, CGMA
Interim Chief Financial Officer
Proven senior financial professional with demonstrated capabilities in preparing companies for strategic transactions and improving under-performing functions
Proven experience in: Acquisitions/Divestitures, Private Equity Ownership, Budgeting and Target Setting, IPO/SEC Reporting, System Implementation, Operational Reporting, Debt Re-Financing, Dual Track Process, Strategic Planning, Financial Forecasting, Treasury, Cost Reductions, Contract Negotiation, Process Improvement, and Alignment/Integration
Career highlights spanning over 38 years include: CFO of PE backed Anthelio Healthcare Solutions (successful exit); SVP Asset Management/Corporate Performance Management at The Brock Group, a $1.4 billion revenue specialty multi-craft services company; SVP/Chief Accounting Officer at PE backed Safety-Kleen Systems with $1.3 billion in revenues (successful exit); and VP Finance and Accounting for Verizon Wireless
Audit and Consulting Manager for PricewaterhouseCoopers and EY, and tax experience with KPMG
DCEO Magazine Chief Accounting Officer of the Year 2011
BBA, CPA, CGMA
Ronald Redmer, MIS
Chief Information Officer
A strategic and results-driven business and technology executive with a proven track record of over three decades leadership in global IT operations, technology startups, major organizational transformations, acquisitions and divestitures, and large-scale solution delivery
Numerous leadership achievements include: Successful exit strategies on more than a dozen companies, including early stage; Established successful (i) public cloud services and open source development company, and (ii) big data analytics and machine learning company serving a diverse customer base including BMW and Infineon; Achieved 50%+ reduction in data center operating expenditures using VMware, Amazon Web Services (AWS), and Microsoft Azure private and hybrid cloud service models; and implemented a factory control system at GM’s largest plant resulting in over $100M/yr. cost savings
Career highlights include: Sr. Director IT, Choctaw Global LLC; Sr. Vice President, Cyber Group; COO/CIO, Assure360; Sr. Technical Leader for Electronic Data Systems (EDS, now Hewlett Packard)) serving General Motors customer
Published in Data Center Journal, Data Center Dynamics and multiple financial publications as a recognized leader in cloud services, IoT and AI. Awarded multiple patents for manufacturing, medical imaging, surveillance and weapon system innovations
Xi Wang, MD, PhD
VP, Clinical Affairs and Strategy
Almost three decades experience with a rare combination of clinical, research, business and medical affairs experiences in both small and large biopharmaceutical industry settings, with specialties including in COPD, Asthma and IPF, CardioMetabolic Diseases, hypertension and bronchoconstrictive diseases, and cardiac physiology, pharmacology and pathology
A comprehensive understanding of healthcare systems and PhRMA code; Strong ability to interact with national and regional key opinion leaders (KOLs), academic investigators, individual healthcare providers, organized customer, payers and internal team members
Career highlights include: Medical Director, Field Group, Pfizer; Senior Medical Science Liaison, Sanofi Genzyme; Senior Medical Science Liaison, Mallinckrodt Pharmaceuticals; and Associate Director, Health Science Executive, Boehringer Ingelheim Pharmaceuticals
Bilingual: fluent in English and Mandarin
John C. Tepper, MSEE
VP, Product Development & Regulatory
Product development, operations, and quality executive with deep experience in program management and design engineering of medical devices, communications & networking systems, power conversion equipment, and industrial control systems
Worked for or consulted to Medtronic, Galt Medical, Orthofix, Intrasafe Medical, Motorola and many others
Inventor or co-inventor on 36 US & International Patents
BSEE, Bioengineering and Biochemistry, Rice University; MSEE from University of Texas
VP, Human Resources and Customer Relations
More than a decade experience in medical devices, emergency medical technologies and oxygen
More than 4 decades of senior management experience in sales, retail, operations and customer service, including Pier One, The Limited Too, and others
Matthew Lipton, Esq.
Licensed attorney and private equity managing partner with decades experience in healthcare, financing, legal and corporate development, in both private and public markets
Companies served include Aspen Strategic Partners, Vissero Partners, Acritas Group, Clear Concepts and Lone Star Angels
Albert DeWeese, BA
Assoc. Director, Quality Control & Project Management
15 Years experience as a medical device expert, CTO, physicist, software developer/manager, test automation engineer and venture capitalist
Worked for or consulted to St. Jude Medical, Medtronic, GE Healthcare, Johnson & Johnson, Cochlear, Abiomed, Abbott, and Alcon
Nikolay Sergeev, PhD
Assoc. Director, Research
Expert molecular biologist with the experience in launching commercial tests for infectious disease diagnostics, liquid biopsy and NIPT
Experiences in leading cross-functional teams with the successful launch of qPCR and NGS-based LDT tests
Experience includes: Sr. Director, R&D at DiaCarta; Principal Scientist, Guardant Health; Principal Scientist at NVS Technologies and five years as a Staff Fellow at the Food & Drug Administration (FDA)
Sheryl Shea, BA
Director, Patient Advocacy
Experienced Educator/Advocate with over 8 years of demonstrated skills, history and success in Customer Service, Sales, Strategic Planning, Leadership, Public Speaking, and Patient Advocacy in the Medical Device industry
BA Political Science and Government from California Polytechnic State University-San Luis Obispo